XELODA

CLASSIFICATION OF DISEASE:

Xeloda is an anticancer medicine. It is used to treat:

•  colon (large bowel) cancer. Xeloda is used with or without other anticancer medicines in patients who have had surgery for ‘stage III’ or ‘Dukes’ stage C’ colon cancer;

•  metastatic colorectal cancer (cancer of the large bowel that has spread to other parts of the body). Xeloda is used with or without other anticancer medicines;

•  advanced gastric (stomach) cancer. Xeloda is used with other anticancer medicines, including a platinum-containing anticancer medicine such as cisplatin;

•  locally advanced or metastatic breast cancer (breast cancer that has begun to spread to other parts of the body). Xeloda is used with docetaxel (another anticancer medicine) after treatment with anthracyclines (another type of anticancer medicine) has failed. It can also be used on its own when treatment with both anthracyclines and taxanes (another type of anticancer medicine) has failed or when repeat treatment with anthracyclines is not suitable for the patient.


Source: www.ema.europa.eu

Summary of the European Public Assessment Report (EPAR): 

Back to Catalogue of Drugs for Rare Diseases